Gretchen Gierach
Gretchen Gierach is a renowned epidemiologist and cancer researcher currently serving as the Deputy Chief of the Epidemiology and Genomics Research Program's (EGRP) Risk Factor Assessment Branch at the National Cancer Institute (NCI). She is recognized for her extensive research in the field of breast cancer epidemiology.
Early Life and Education[edit | edit source]
Gretchen Gierach was born and raised in the United States. She completed her undergraduate studies in biology and chemistry before pursuing a Master's degree in Public Health and a Doctorate in Epidemiology.
Career[edit | edit source]
Gierach started her career as a researcher, focusing on the epidemiology of breast cancer. She joined the National Cancer Institute, where she currently serves as the Deputy Chief of the EGRP's Risk Factor Assessment Branch. Her work primarily involves studying the etiology and prevention of breast cancer, with a particular focus on understanding the role of mammographic density in breast cancer risk and progression.
Research[edit | edit source]
Gierach's research has significantly contributed to the understanding of breast cancer. She has conducted several studies investigating the relationship between mammographic density and breast cancer risk. Her work has also explored the influence of hormones and growth factors on the development and progression of breast cancer.
Publications[edit | edit source]
Gierach has authored and co-authored numerous scientific publications in the field of cancer epidemiology. Her work has been published in several prestigious medical journals, including the Journal of the National Cancer Institute and the Journal of Clinical Oncology.
Awards and Recognition[edit | edit source]
Gierach's contributions to cancer research have earned her several awards and recognitions. She is a respected figure in the field of epidemiology and is often invited to speak at national and international conferences.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD